Selenoproteins, Cholesterol-Lowering Drugs, and the Consequences Revisiting of the Mevalonate Pathway

This publication has 117 references indexed in Scilit:

• β-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization
  American Heart Journal, 2003
• Simvastatin Normalizes Autonomic Neural Control in Experimental Heart Failure
  Circulation, 2003
• The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
  Nature, 2002
• Thioredoxin Reductase Reduces Lipid Hydroperoxides and Spares α-Tocopherol
  Biochemical and Biophysical Research Communications, 2002
• Oxidation Injury in Patients Receiving HMG-CoA Reductase Inhibitors
  Drug Safety, 2002
• Effects of selenium and vitamin E on the immune responses of domestic animals
  Research in Veterinary Science, 1996
• Decreased glutathione peroxidase activity in mice in response to nafenopin is caused by changes in selenium metabolism
  Chemico-Biological Interactions, 1996
• Reversal of lovastatin‐mediated inhibition of natural killer cell cytotoxicity by interleukin 2
  Journal of Cellular Physiology, 1990
• Drug Interaction between Thyroxine and Lovastatin
  New England Journal of Medicine, 1989
• Inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase in cultured L cells by the hypocholesterolemic drug clofibrate
  Biochemical and Biophysical Research Communications, 1977